# The Role of Serum Anticholinergic Activity in ACVB Patients

> **NCT00782938** · — · COMPLETED · sponsor: **Heidelberg University** · enrollment: 100 (estimated)

## Conditions studied

- Acetylcholine
- Cognition
- BIS-EEG

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00782938
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-12
- **Final completion:** 2010-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2010-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00782938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00782938, "The Role of Serum Anticholinergic Activity in ACVB Patients". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00782938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*